Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Artigo
|
![]() |
Olanzapine-induced delayed-onset oculogyric crisisIspir, Mustafa ; Bakkal, Osman ; Gundogmus, Ibrahim ; Algul, AyhanAnadolu psikiyatri dergisi, 2017-06, Vol.18 (3) [Periódico revisado por pares]Anadolu Psikiyatri DergisiTexto completo disponível |
12 |
Material Type: Artigo
|
![]() |
Nitrogen and sulfur co-doped graphene quantum dots/nanocellulose nanohybrid for electrochemical sensing of anti-schizophrenic drug olanzapine in pharmaceuticals and human biological fluidsMahmoud, Ashraf M. ; Mahnashi, Mater H. ; Alkahtani, Saad A. ; El-Wekil, Mohamed M.International journal of biological macromolecules, 2020-12, Vol.165 (Pt B), p.2030-2037 [Periódico revisado por pares]Netherlands: Elsevier B.VTexto completo disponível |
13 |
Material Type: Artigo
|
![]() |
Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity EvaluationKhan, Kifayat Ullah ; Akhtar, Naveed ; Minhas, Muhammad UsmanAAPS PharmSciTech, 2020-05, Vol.21 (5), p.141 [Periódico revisado por pares]United StatesTexto completo disponível |
14 |
Material Type: Artigo
|
![]() |
Quantification of Olanzapine by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)Johnson-Davis, Kamisha L. ; Ly, Diane Garg, UttamClinical Applications of Mass Spectrometry in Drug Analysis, 2024, Vol.2737, p.347-357New York, NY: Springer USSem texto completo |
15 |
Material Type: Artigo
|
![]() |
Olanzapine: inconclusive findings after two deaths in 2013WHO drug information, 2015-03, Vol.29 (2), p.149Geneva: World Health OrganizationTexto completo disponível |
16 |
Material Type: Artigo
|
![]() |
Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluationKhallaf, Rasha A. ; Aboud, Heba M. ; Sayed, Ossama M.Journal of liposome research, 2020-04, Vol.30 (2), p.163-173 [Periódico revisado por pares]England: Taylor & FrancisTexto completo disponível |
17 |
Material Type: Artigo
|
![]() |
A prospective randomized controlled clinical trial investigating the efficacy of low-dose olanzapine in preventing nausea and vomiting associated with oxaliplatin-based and irinotecan-based chemotherapyShen, Jing ; Zhao, Juan ; Jin, Gaowa ; Li, Hui ; Jiang, Ying ; Wu, Yungaowa ; Gao, Jiali ; Chen, Feng ; Li, Jiaxuan ; Wang, Wenjuan ; Li, QuanfuJournal of cancer research and clinical oncology, 2024-05, Vol.150 (5), p.283, Article 283 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
18 |
Material Type: Artigo
|
![]() |
Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteersZubiaur, Pablo ; Soria-Chacartegui, Paula ; Koller, Dora ; Navares-Gómez, Marcos ; Ochoa, Dolores ; Almenara, Susana ; Saiz-Rodríguez, Miriam ; Mejía-Abril, Gina ; Villapalos-García, Gonzalo ; Román, Manuel ; Martín-Vílchez, Samuel ; Abad-Santos, FranciscoBiomedicine & pharmacotherapy, 2021-01, Vol.133, p.111087, Article 111087 [Periódico revisado por pares]France: Elsevier Masson SASTexto completo disponível |
19 |
Material Type: Artigo
|
![]() |
Olanzapine for chemotherapy-induced nausea and vomiting control – Authors’ replyBajpai, Jyoti ; Pawar, Akash ; Kapu, Venkatesh ; Prabhash, KumarThe lancet oncology, 2024-05, Vol.25 (5), p.e177-e177 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
20 |
Material Type: Artigo
|
![]() |
Olanzapine for chemotherapy-induced nausea and vomiting controlTsuruta, Seiji ; Matsuguma, Kunihito ; Kawasaki, Naruaki ; Ishikawa, Ayaka ; Ishiki, HirotoThe lancet oncology, 2024-05, Vol.25 (5), p.e176-e176 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |